Is This Elon's Worst Nightmare?

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga Insights
September 26, 2025

Gainers

  • Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
  • Applied Therapeutics (NASDAQ: APLT) shares moved upwards by 65.7% to $0.93. The company's market cap stands at $80.6 million.
  • bioAffinity Technologies (NASDAQ: BIAF) stock increased by 58.21% to $5.39. The company's market cap stands at $4.5 million.
  • Crinetics Pharmaceuticals (NASDAQ: CRNX) shares increased by 27.48% to $45.75. The company's market cap stands at $3.3 billion.
  • Strata Skin Sciences (NASDAQ: SSKN) shares moved upwards by 25.51% to $2.46. The company's market cap stands at $10.3 million.
  • Fractyl Health (NASDAQ: GUTS) shares rose 22.93% to $1.24. The market value of their outstanding shares is at $71.5 million.

Losers

  • Lexaria Bioscience (NASDAQ: LEXX) shares declined by 28.1% to $1.1 during Friday's regular session. The market value of their outstanding shares is at $29.9 million.
  • Soligenix (NASDAQ: SNGX) stock fell 25.93% to $1.2. The company's market cap stands at $6.9 million.
  • SciSparc (NASDAQ: SPRC) stock decreased by 24.31% to $4.61. The market value of their outstanding shares is at $3.2 million.
  • Zhengye Biotechnology (NASDAQ: ZYBT) stock fell 21.67% to $2.35. The market value of their outstanding shares is at $142.1 million.
  • PepGen (NASDAQ: PEPG) stock declined by 17.35% to $4.86. The market value of their outstanding shares is at $192.8 million.
  • CASI Pharmaceuticals (NASDAQ: CASI) stock decreased by 16.62% to $1.26. The company's market cap stands at $23.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Trump files $15 billion defamation lawsuit against The New York Times

NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

What a possible Fed rate cut would mean for your finances

NEW YORK (AP) — The Federal Reserve is expected to cut its benchmark interest rate Wednesday for the first time in nine months. Since the last cut, while the . That means Americans are dealing with both high prices and a challenging job market.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Lennar Shares Are Trading Lower Friday: What's Going On?

Lennar shares are trading lower Friday after the company reported worse-than-expected third quarter financial results on Thursday after the market closed.

European Central Bank expected to keep rates on hold as economy weathers Trump's tariffs

FRANKFURT, Germany (AP) — Inflation is back under control, and the European economy is weathering Trump's tariff onslaught better than expected. Those are reasons the European Central Bank is expected to keep its benchmark interest rate unchanged Thursday.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

India retires MiG-21 fighters after six decades as air force stretches to improve fleet

NEW DELHI (AP) — India retired its last fleet of Soviet-era MiG-21 fighter jets Friday, ending more than six decades of service with an aircraft once celebrated for its combat prowess but later derided as a “flying coffin” due to frequent crashes.

DraftKings (DKNG) Stock Pressured By Bear Cave Report On Growing Prediction Market Threat

Shares of DraftKings are trading off session highs Thursday. The stock is volatile following a new report from The Bear Cave highlighting a growing competitive threat from prediction markets.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Elon Musk's xAI Reportedly Lays Off 500 Workers From Data Annotation Team As Startup Pivots To Specialist AI Tutors For Grok Expansion

Elon Musk's xAI has laid off about 500 data annotators in a major restructuring, shifting focus to specialist AI tutors to accelerate Grok's development despite recently securing $10 billion in new funding.

What's Going On With UniQure Stock Wednesday?

UniQure N.V. (NASDAQ:QURE) shares are trading higher Wednesday after the company announced positive topline results from Phase I/II study of AMT-130 in patients with Huntington's Disease.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership

Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership.

Long-wrought WTO agreement aimed at reducing overfishing takes effect

GENEVA (AP) — A World Trade Organization agreement aimed at reducing took effect Monday, requiring countries to reduce subsidies doled out to fishing fleets and aiming to ensure sustainability of wildlife in the world's seas and oceans.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Bank of England holds main UK interest rate at 4% with inflation above target

LONDON (AP) — The Bank of England held its main interest rate at 4% on Thursday as U.K. inflation concerns weigh on policymakers.

Taiwan Semiconductor To Strengthen Chipmaking Network With Pingtung Service Hub

TSM to launch multifunctional service center in Taiwan to boost high-tech facility construction. Stock up 31% YTD.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Asian shares mostly climb after US stocks remained near record levels following the Fed's rate cut

MANILA, Philippines (AP) — Asian shares, led by tech stocks, were mostly higher Thursday after Wall Street indexes churned between gains and losses but ultimately remained near their record levels following the Federal Reserve’s decision to cut its main interest rate.

Gen Z Is Rewriting Luxury — Can KLXY And FINE ETFs Keep Up?

Gen Z is redefining the luxury playbook. Logos are so last season, digital culture is on the rise, sustainability is a given, and affordable prestige is as strong as heritage, found Reuters in a survey.

Nvidia Is About to Shock the World: October 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Why Rivian Automotive Stock Is Gaining Today?

Rivian stock climbs after breaking ground on a multibillion-dollar Georgia EV plant.

Elizabeth Warren, Jack Reed Warn SEC Against 'Significant Mistake' Of Curbing Shareholder Lawsuits Against Companies: Report

Sen. Elizabeth Warren (D-Mass) and other democrats have issued a stern warning to the Securities and Exchange Commission (SEC) against any potential policy change that could limit shareholders' ability to sue companies.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

‘Race against time’ to remove rubble after recent earthquake in Afghanistan’s east, says UN

The United Nations says aid workers are still in a “race against time” to remove rubble and rebuild after the eastern Afghanistan last month, killing at least 2,200 people and cutting off remote areas.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Ex-Trump Lawyer Draws Parallels Between Kimmel Suspension And Nazi Regime

Ty Cobb has drawn a comparison between the suspension of comedian Jimmy Kimmel and the tactics employed by the Nazis.

Small Caps Rally, Intel Rockets On Best Day Ever: What's Moving Markets Thursday?

The Russell 2000, which tracks small caps, rallied on Thursday, outpacing large-cap benchmarks as investors piled into interest-rate-sensitive stocks a day after the Federal Reserve cut rates by 25 basis points and signaled more easing ahead

Is Elon's Empire Crumbling? - Ad

Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after October 23rd, it may be too late.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

North Carolina judge orders $50M payment for helicopter crash death

CHARLOTTE, N.C. (AP) — A North Carolina judge has ordered $50 million be paid to the family of a Charlotte TV station meteorologist who was killed in a after finding the companies that owned and operated the aircraft liable in his widow's wrongful death lawsuit.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.

UN report cites huge government corruption in South Sudan as its food crisis worsens

NAIROBI, Kenya (AP) — Billions of dollars in public funds in South Sudan have been stolen over the past decade in massive government corruption while the vast majority of the country suffers food insecurity, a U.N. commission said Tuesday.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service